NP0079-C, NP0079-16H

General

Cell Line

hPSCreg name UKKi034-C
Cite as:
UKKi034-C (RRID:CVCL_VF41)
Alternative name(s)
NP0079-C, NP0079-16H
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UKKi034-A
(NP0079-A, NP0079-7B)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi034-B
(NP0079-B, NP0079-15B)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
Familial long QT syndrome
TAUi006-A
(UTA.00102.LQT1)
Donor's gene variants:
KCNQ1 – potassium voltage-gated channel subfamily Q member 1
Donor diseases:
Long QT Syndrome 1
TAUi006-B
(UTA.00118.LQT1)
Donor's gene variants:
KCNQ1 – potassium voltage-gated channel subfamily Q member 1
Donor diseases:
Long QT Syndrome 1
TAUi007-A
(UTA.00208.LQT1)
Donor's gene variants:
KCNQ1 – potassium voltage-gated channel subfamily Q member 1
Donor diseases:
Long QT Syndrome 1
TAUi007-B
(UTA.00211.LQT1)
Donor's gene variants:
KCNQ1 – potassium voltage-gated channel subfamily Q member 1
Donor diseases:
Long QT Syndrome 1
LUMCi039-A
(LQT1-1781G/A hiPSC, LUMC0021iKCNQ-30)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
Long QT Syndrome 1
UKKi029-A
(NP0077-6D)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi029-B
(NP0077-16E)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi029-C
(NP0077-18C)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi016-B
(NP0078-12)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi016-C
(NP0078-13)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi016-A
(NP0078-10)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
NUIGi005-A
(LQTS004C7, LQT004C7)
Donor diseases:
Long QT Syndrome 1
NUIGi005-B
(LQTS004C9, LQT004C9)
Donor diseases:
Long QT Syndrome 1
NUIGi005-C
(LQTS004Cx, LQT004Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi008-A
(LQTS007C1)
Donor diseases:
Long QT Syndrome 1
NUIGi008-B
(LQTS007C2)
Donor diseases:
Long QT Syndrome 1
NUIGi008-C
(LQTS007Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi009-A
(LQTS008C1)
Donor diseases:
Long QT Syndrome 1
NUIGi009-B
(LQTS008C6)
Donor diseases:
Long QT Syndrome 1
NUIGi009-C
(LQTS008Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi011-A
(LQTS010C3)
Donor diseases:
Long QT Syndrome 1
NUIGi011-B
(LQTS010C4)
Donor diseases:
Long QT Syndrome 1
NUIGi011-C
(LQTS010Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi006-A
(LQTS005C2, LQT005C2)
Donor diseases:
Long QT Syndrome 1
NUIGi006-B
(LQTS005C4, LQT005C4)
Donor diseases:
Long QT Syndrome 1
NUIGi006-C
(LQTS005Cx, LQT005Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi007-A
(LQTS006C6, LQT006C6)
Donor diseases:
Long QT Syndrome 1
NUIGi007-B
(LQTS006C8, LQT006C8)
Donor diseases:
Long QT Syndrome 1
NUIGi010-A
(LQTS009C2)
Donor diseases:
Long QT Syndrome 1
NUIGi010-B
(LQTS009C3)
Donor diseases:
Long QT Syndrome 1
NUIGi010-C
(LQTS009Cx)
Donor diseases:
Long QT Syndrome 1
INSRMi021-A
(PC177 3c14)
Donor diseases:
myofibrillar myopathy 1
PUMCHi002-A
(20180908R-AE3, PUMCH-IRC)
Donor diseases:
Restrictive Cardiomyopathy
ITXi004-A
(MS381)
Donor diseases:
Long QT Syndrome
FAMRCi006-A
(LMNA T3)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
FAMRCi006-B
(LMNA T4)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
UKKi031-A
(NP0138-8B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-B
(NP0138-19E)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
UKKi031-C
(NP0138-31B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
USFi003-A
(1AB1)
Donor diseases:
Dilated Cardiomyopathy
YUCMi022-A
(hiPSC-KCNH2_G53S)
Donor diseases:
Long QT Syndrome
Last update 18th October 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Klinikum der Universität zu Köln (UKK)
Distributors
Derivation country Germany

External Databases

BioSamples SAMEA104615858
EBiSC UKKi034-C
Cellosaurus CVCL_VF41
Wikidata Q54990540

General Information

Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 30-34

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
KCNQ1, heterozygous mutation, c.830C>T, p.Ser277Leu
The donor is affected.
Synonyms
  • Congenital long QT syndrome
  • LQTS
Genetic variants
KCNQ1 (target)
11p15.5-p15.4
NM_000218.2:c.830C>T
NP_000209.2:p.Ser277Leu
Heterozygous
Family history no
Is the medical history available upon request? yes
Is clinical information available? yes

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA104615902

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink Tomo Saric
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Yes
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? Yes
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent expressly permit storage of donated embryo/tissue for an unlimited time? Yes
Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? Yes
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
Does consent expressly permit collection of genetic information? Yes
Does consent expressly permit storage of genetic information? Yes
Does consent prevent dissemination of genetic information? No
Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens? Yes
Has the donor consented to receive information discovered during use of donated embryo/tissue that has significant health implications for the donor? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Does consent permit access to medical records of the donor? Yes
Please describe how access is provided: Clinic in which the donor was recruted holds the medical records
Does consent permit access to any other source of information about the clinical treatment or health of the donor? Yes
Contact data, institution, or website:
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Independent Ethics Committee of the Faculty of Medicin of the University of Cologne
Approval number DRKS00009433
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Committee of the Faculty of Medicin of the University of Cologne
Approval number DRKS00009433
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
Is there an MTA available for the cell line? Yes
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? Thermo Fisher, Cyto Tune-iPS 2.0 Sendai Reprogramming Kit
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.
Age of donor (at collection) 30-34
Collected in 2017
Passage number reprogrammed 0

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Type of used vector free reprogramming factor(s)
None

Other

Selection criteria for clones morphology
Derived under xeno-free conditions
Yes
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium Other medium:
Base medium: StemFlex
Main protein source:
Serum concentration: %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
OCT 4
Yes
TRA 1-80
Yes
NANOG
Yes
SSEA-4
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
BRACHYURY
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
NES
Yes
Morphology

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
No larger chromosomal aberrations to be reported; Chr15: Duplication in q11.2 on
Passage number: 20

Other Genotyping (Cell Line)

Is there genome-wide genotyping or functional data available?
Yes